Quantbot Technologies LP Nuvation Bio Inc. Transaction History
Quantbot Technologies LP
- $2.88 Billion
- Q1 2025
A detailed history of Quantbot Technologies LP transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 23,897 shares of NUVB stock, worth $53,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,897
Previous 31,345
23.76%
Holding current value
$53,290
Previous $83,000
49.4%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NUVB
# of Institutions
173Shares Held
157MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$57.9 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$36.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$34.3 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$29.2 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$22 Million0.45% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $484M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...